Analysis of familial exudative vitreoretinopathy (FEVR) cases in the UK 100 000 genomes project increases diagnostic rate and implicates heterozygous CTNND1 mutations in FEVR
Open Access
- 18 December 2025
- journal article
- vision science
- Published by BMJ in Journal of Medical Genetics
- Vol. 63 (3) , 187-196
Abstract
Background: Familial exudative vitreoretinopathy (FEVR) is an inherited eye disease characterised by the incomplete development of the retinal vasculature. Over 10 genes have been associated with FEVR, but there are still a substantial number of genetically unsolved cases. The aim of this study was to analyse whole genome sequencing (WGS) data from the FEVR cases in the Genomics England (GEL) 100 000 genomes project to identify the causative variants. Methods: WGS was performed by GEL and accessed within the GEL Research Environment. FEVR cases were identified using LabKey and candidate variants were extracted using the ‘gene-variant workflow’ and ‘CNV/SV workflow’ and by using BCFtools in unfiltered VCF files. Results: Fifty-nine FEVR probands were submitted to GEL. We found six novel and eight previously reported pathogenic variants in six genes known to underlie FEVR ( TSPAN12, LRP5, FZD4, CTNNB1, KIF11 and NDP ), as well as structural variants in TSPAN12 and KIF11 . These accounted for 15/59 (25.4%) of FEVR cases. We also found candidate heterozygous variants in CTNND1 in three unsolved FEVR cases. Expanding the list of genes examined to include all genes reported to be mutated in ocular disorders likely solved a further four cases, indicating that these individuals may be misclassified as FEVR in GEL. Conclusion: By performing bespoke reanalysis of the FEVR GEL cohort, this study has highlighted additional heterozygous variants in CTNND1 in FEVR cases and increased the diagnostic yield from 20% solved by the GEL analysis pipeline to 37% (22/59), but the majority of FEVR cases remain without a molecular diagnosis.Keywords
Funding Information
- University Postgraduate Programme
- UK Research and Innovation (MR/Y034325/1)
- Retinitis Pigmentosa Fighting Blindness and Fight for Sight UK (RP Genome Project GR586)
This publication has 53 references indexed in Scilit:
- Unlocking the potential of the UK 100,000 Genomes Project—lessons learned from analysis of the “Congenital Malformations caused by Ciliopathies” cohortAmerican Journal of Medical Genetics Part C: Seminars in Medical Genetics, 2022
- A novel PAX2 heterozygous mutation in a family with Papillorenal syndrome: A case report and review of the literatureAmerican Journal of Ophthalmology Case Reports, 2021
- Structural Variants Create New Topological-Associated Domains and Ectopic Retinal Enhancer-Gene Contact in Dominant Retinitis PigmentosaThe American Journal of Human Genetics, 2020
- Clinical and Molecular Characterization of Familial Exudative Vitreoretinopathy Associated With MicrocephalyAmerican Journal of Ophthalmology, 2019
- Predicting Splicing from Primary Sequence with Deep LearningCell, 2019
- Defects in the Cell Signaling Mediator β-Catenin Cause the Retinal Vascular Condition FEVRThe American Journal of Human Genetics, 2017
- Phenotypic Overlap Between Familial Exudative Vitreoretinopathy and Microcephaly, Lymphedema, and Chorioretinal Dysplasia Caused byKIF11MutationsJAMA Ophthalmology, 2014
- De novo mutations in beta-catenin (CTNNB1) appear to be a frequent cause of intellectual disability: expanding the mutational and clinical spectrumHuman Genetics, 2014
- Overview of the mutation spectrum in familial exudative vitreoretinopathy and Norrie disease with identification of 21 novel variants in FZD4, LRP5, and NDPHuman Mutation, 2010
- Mutations in TSPAN12 Cause Autosomal-Dominant Familial Exudative VitreoretinopathyThe American Journal of Human Genetics, 2010